跳至主要内容
临床试验/CTRI/2019/08/020653
CTRI/2019/08/020653招募中未知

Desmopressin Reduces Bleeding Risk after Percutaneous Kidney Biopsy : A Randomized Controlled Study

SGPGI0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients who will undergo kidney biopsy; irrespective of cause and degree of renal dysfunction or proteinuria or hematuria

排除标准

  • Ascites, volume overload, parietal edema.
  • Structural renal disease - Renal calculus disease, hydroureteronephrosis, cystic disease, tumor and CAKUT.
  • Solitary single kidney or unequal kidney size or bilateral small kidneys
  • BMI more than or equal to 25 kg/m2.
  • Patients not able to hold breath.
  • Patients on anticoagulant or anti-platelet drugs.
  • Bleeding or clotting disorders.
  • Coronary artery disease, congestive cardiac failure or volume overload
  • Serum sodium less than 130 mEq/l
  • Kidney transplant recipients
  • Pregnancy and Lactation

研究者

发起方
SGPGI

相似试验